The Regulation of Autophagy by the MiR-199a-5p/p62 Axis Was a Potential Mechanism of Small Cell Lung Cancer Cisplatin Resistance

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2022 Mar 16

PMID 35292022

Authors

Tiezhi Li

Helin Zhang

Zhichao Wang

Shaolin Gao

Xu Zhang

Haiyong Zhu

Na Wang

Honglin Li

Affiliations

Soon will be listed here.

Abstract

Background: Autophagy has been found to be involved in the multidrug resistance (MDR) of cancers, but whether it is associated with resistance of small cell lung cancer (SCLC) has not been studied. Here, we hypothesized that a potential autophagy-regulating miRNA, miR-199a-5p, regulated cisplatin-resistant SCLC.

Methods: We validated the MDR of H446/EP using CCK-8 and LDH. We tested the binding of miR-199a-5p to p62 using the Dual-Luciferase assay and validated the association of miR-199a-5p and p62 in SCLC samples. We overexpressed (OE) and knocked down (KD) miR-199a-5p in H446 and H446/EP and determined the expression of miR-199a-5p, autophagy-related proteins, and the formation of autophagolysosomes using QPCR, western blotting, and MDC staining respectively. These results were validated in an orthotopic H446 mouse model of SCLC.

Results: H446/EP was resistant to cisplatin, etoposide, paclitexal, epirubicin, irinotecan, and vinorelbine. Exposure of cisplatin at 5 μg/ml for 24 h increased LC3II/LC3I, ATG5, p62, and the formation of autophagolysosomes in H446 cells, but not in H446/EP cells. The expression of miR-199a-5p was up-regulated in H446/EP compared to H446. MiR-199a-5p directly targeted the p62 gene. The expression of miR-199a-5p and p62 were correlated in SCLC samples. In H446 and H69PR, the OE of miR-199a-5p increased LC3II/LC3I, p62, and the formation of autophagolysosomes, but not ATG5, while the KD of miR-199a-5p decreased p62, but did not affect LC3II/LC3I, ATG5, and the formation of autophagolysosomes. In H446/EP, the OE of miR-199a-5p decreased p62 only. These results were generally consistent to results in the animal tumor samples.

Conclusions: The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance.

Citing Articles

MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells.

Tolue Ghasaban F, Maharati A, Akhlaghipour I, Moghbeli M Cancer Cell Int. 2023; 23(1):80.

PMID: 37098542 PMC: 10127417. DOI: 10.1186/s12935-023-02925-7.

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers.

Zhang L, Ye B, Chen Z, Chen Z Acta Pharm Sin B. 2023; 13(3):982-997.

PMID: 36970215 PMC: 10031261. DOI: 10.1016/j.apsb.2022.10.002.

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer.

Mondal P, Meeran S Front Pharmacol. 2023; 14:1105484.

PMID: 36778005 PMC: 9909610. DOI: 10.3389/fphar.2023.1105484.

Brain-protective mechanisms of autophagy associated circRNAs: Kick starting self-cleaning mode in brain cells circRNAs as a potential therapeutic approach for neurodegenerative diseases.

Basri R, Awan F, Yang B, Awan U, Obaid A, Naz A Front Mol Neurosci. 2023; 15:1078441.

PMID: 36727091 PMC: 9885805. DOI: 10.3389/fnmol.2022.1078441.

Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment.

Song K, Yu Z, Zu X, Li G, Hu Z, Xue Y Int J Mol Sci. 2022; 23(18).

PMID: 36142424 PMC: 9502421. DOI: 10.3390/ijms231810509.

References

Utaipan T, Athipornchai A, Suksamrarn A, Chunsrivirot S, Chunglok W . Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells. Oncol Rep. 2017; 37(2):1243-1252. DOI: 10.3892/or.2017.5352. View

Liu H, Qie P, Yang G, Song Y . miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2. Arch Med Sci. 2018; 14(4):745-751. PMC: 6040135. DOI: 10.5114/aoms.2018.73131. View

Wu Q, Yang Z, Nie Y, Shi Y, Fan D . Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014; 347(2):159-66. DOI: 10.1016/j.canlet.2014.03.013. View

Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L . LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol. 2019; 12(1):91. PMC: 6728969. DOI: 10.1186/s13045-019-0773-y. View

Li R, Xiao C, Liu H, Huang Y, Dilger J, Lin J . Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer. 2018; 18(1):666. PMC: 6006780. DOI: 10.1186/s12885-018-4576-2. View

Liu H, Dilger J, Lin J . Lidocaine Suppresses Viability and Migration of Human Breast Cancer Cells: TRPM7 as a Target for Some Breast Cancer Cell Lines. Cancers (Basel). 2021; 13(2). PMC: 7827240. DOI: 10.3390/cancers13020234. View

Pankiv S, Clausen T, Lamark T, Brech A, Bruun J, Outzen H . p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007; 282(33):24131-45. DOI: 10.1074/jbc.M702824200. View

Li X, He S, Ma B . Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020; 19(1):12. PMC: 6975070. DOI: 10.1186/s12943-020-1138-4. View

Li Y, Wang D, Li X, Shao Y, He Y, Yu H . MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11. J Cancer. 2019; 10(11):2472-2479. PMC: 6584351. DOI: 10.7150/jca.29426. View

10.

Li Y, Lei Y, Yao N, Wang C, Hu N, Ye W . Autophagy and multidrug resistance in cancer. Chin J Cancer. 2017; 36(1):52. PMC: 5482965. DOI: 10.1186/s40880-017-0219-2. View

11.

Clement T, Salone V, Rederstorff M . Dual luciferase gene reporter assays to study miRNA function. Methods Mol Biol. 2015; 1296:187-98. DOI: 10.1007/978-1-4939-2547-6_17. View

12.

Pan B, Chen Y, Song H, Xu Y, Wang R, Chen L . Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Oncotarget. 2014; 6(1):317-31. PMC: 4381597. DOI: 10.18632/oncotarget.2787. View

13.

Liu X, Liu H, Xiong Y, Yang L, Wang C, Zhang R . Postmenopausal osteoporosis is associated with the regulation of SP, CGRP, VIP, and NPY. Biomed Pharmacother. 2018; 104:742-750. DOI: 10.1016/j.biopha.2018.04.044. View

14.

Li Y, Jiang W, Hu Y, Da Z, Zeng C, Tu M . MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells. Oncol Lett. 2016; 12(5):4203-4208. PMC: 5104258. DOI: 10.3892/ol.2016.5172. View

15.

Zhu Q, Zhou Q, Dong L, Huang Z, Wu F, Deng X . MiR-199a-5p Inhibits the Growth and Metastasis of Colorectal Cancer Cells by Targeting ROCK1. Technol Cancer Res Treat. 2018; 17:1533034618775509. PMC: 5974564. DOI: 10.1177/1533034618775509. View

16.

Li R, Liu H, Dilger J, Lin J . Effect of Propofol on breast Cancer cell, the immune system, and patient outcome. BMC Anesthesiol. 2018; 18(1):77. PMC: 6020422. DOI: 10.1186/s12871-018-0543-3. View

17.

Li X, Peng B, Zhu X, Wang P, Xiong Y, Liu H . Changes in related circular RNAs following ERβ knockdown and the relationship to rBMSC osteogenesis. Biochem Biophys Res Commun. 2017; 493(1):100-107. DOI: 10.1016/j.bbrc.2017.09.068. View

18.

Ahmadi A, Khansarinejad B, Hosseinkhani S, Ghanei M, Mowla S . miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer. Gene. 2017; 620:15-22. DOI: 10.1016/j.gene.2017.03.032. View

19.

Wu Z, Ou L, Wang C, Yang L, Wang P, Liu H . Icaritin induces MC3T3-E1 subclone14 cell differentiation through estrogen receptor-mediated ERK1/2 and p38 signaling activation. Biomed Pharmacother. 2017; 94:1-9. DOI: 10.1016/j.biopha.2017.07.071. View

20.

Komatsu M, Kageyama S, Ichimura Y . p62/SQSTM1/A170: physiology and pathology. Pharmacol Res. 2012; 66(6):457-62. DOI: 10.1016/j.phrs.2012.07.004. View